Letter: Remnant Cholesterol and No-Reflow in STEMI: Considerations on Endpoint Definition, Confounding, and Validation

Angiology 2026

View at publisher

Authors: Oğuzhan Yılmaz, Özden Seçkin, Serkan Ünlü

DOI: 10.1177/00033197261427073

Cited by: 1

References: 5

Fields of Study & Subjects

Diabetes Cardiovascular Risks and Lipoproteins Lipoproteins and Cardiovascular Health Cancer Lipids and Metabolism

References 5